TD Cowen Lifts Tempus AI (TEM) Price Target on Genomic Volumes Growth
Tempus AI, Inc. (NASDAQ:TEM) in Cathie Wood's stock portfolio is one of the top 10 stocks to buy now.
Tempus Ai Inc. (TEM)
Market is closed
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $75.61 | 132 | $9,980.52 | 132,056 | 2025-08-19 | Filing | |
| $74.63 | 5,266 | $393,001.58 | 132,188 | 2025-08-19 | Filing | |
| $75.61 | 89 | $6,729.29 | 94,115 | 2025-08-19 | Filing | |
| $74.63 | 3,575 | $266,802.25 | 94,204 | 2025-08-19 | Filing | |
| $69.90 | 44,000 | $3,075,600.00 | 86,756 | 2025-08-13 | Filing |
News See All
Cathie Wood Stock Portfolio: Top 10 Stocks to Buy Now
Cathie Wood, the CEO and chief investment officer of ARK Investment Management, has established a reputation thanks to high-conviction bets that often yield significant returns.
Tempus AI, Inc. (NASDAQ:TEM) Q2 2025 Earnings Call Transcript
Operator: Thank you for standing by, and welcome to Tempus AI Second Quarter 2025 Financial Results Conference Call.
Tempus AI (TEM) Secures FDA Clearance for AI-Powered Heart Monitoring Software
Tempus AI, Inc. (NASDAQ:TEM) is one of the top 10 medical AI companies to buy according to analysts.
Top 10 Medical AI Companies to Buy According to Analysts
Artificial intelligence is transforming medical sciences in ways not seen before.
Do You Believe in the Growth Potential of Tempus AI (TEM)?
Patient Capital Management, a value investing firm, released its “Patient Capital Opportunity Equity Strategy” second-quarter 2025 investor letter. A copy of the letter can be downloaded here.
Tempus AI, Inc. (TEM) and Personalis Join Forces to Take on Colorectal Cancer
On July 10, 2025, Tempus AI, Inc. (NASDAQ:TEM) announced an update about its strategic partnership with Personalis.
Jim Cramer Notes Tempus AI is "Losing Money Hand Over Fist"
Tempus AI (NASDAQ:TEM) provides advanced healthcare technology solutions, including molecular diagnostics, data analytics platforms, and clinical trial matching services for the medical and life sciences...
Tempus AI Expands "Tempus Next" Platform to Improve Breast Cancer Care with AI-Driven Insights.
Tempus AI Inc. (NASDAQ:TEM) is one of the best young stocks to buy and hold for 5 years.
Top 10 AI Infrastructure Stocks to Buy Now
The global AI infrastructure market is projected to grow at a CAGR of 29.1%, reaching $356.14 billion by 2032 from $36.59 billion in 2023, according to Fortune Business Insights.
Billionaire Hedge Funds
